CROI 2016 Program at a Glance

Program and Agenda

Session P-S4 Poster Abstracts

Hall D

788 Point-of-Care p24 Infant Testing May Increase Patient Yield Despite Low Sensitivity Bindiya Meggi 1 ; Nedio Mabunda 1 ; AdolfoVubil 1 ; Osvaldo Loquilha 2 ; Jorge I. Quevedo 3 ; OceanTobaiwa 3 ;Timothy Bollinger 3 ; LaraVojnov 3 ; Trevor Peter 4 ; IleshV. Jani 5 1 InstNacionaldeSaúdedeMocambique,Maputo,Mozambique; 2 Univ EduardoMondlane,Maputo,Mozambique; 3 ClintonHlthAccess Initiative,

2:45 PM-4:00 PM MTCT: Regimens, Rates, and Early Infant Diagnosis 782 Population-Level Declines in Vertical HIV Transmission With Changing PMTCT Guidelines Jean Maritz 1 ; Nei-Yuan Hsiao 2 ;Wolfgang Preiser 1 ; Landon Myer 2 1 StellenboschUniv,CapeTown,SouthAfrica; 2 UnivofCapeTown,Cape Town,SouthAfrica 783 Introduction of Birth Testing Into the South African National Consolidated Guidelines Ahmad Haeri Mazanderani 1 ;Tendesayi Kufa-Chakezha 1 ; Gayle Sherman 2 1 NICD, Johannesburg,SouthAfrica; 2 Univof theWitwatersrand, Johannesburg,SouthAfrica 784 Infant Cotrimoxazole Prophylaxis AssociatedWith Commensal Bacterial Resistance 1 MassachusettsGeneralHosp,Boston,MA,USA; 2 UnivofBotswana, Gaborone,Botswana; 3 BrighamandWomen'sHosp,HarvardMedSch, Boston,MA,USA; 4 BotswanaHarvardAIDS InstPartnership,Gaborone, Botswana; 5 BennettStatisticalConsulting, Inc,BallstonLake,NY,USA; 6 HarvardSchofPH,Boston,MA,USA; 7 BotswanaHarvardAIDS Inst Partnership,Gaborone,Botswana 785 Low Uptake of Routine Infant Diagnostic Testing Following HIV PCR Testing at Birth Jean Maritz 1 ; Nei-Yuan Hsiao 2 ;Wolfgang Preiser 1 ; Landon Myer 2 1 StellenboschUniv,CapeTown,SouthAfrica; 2 UnivofCapeTown,Cape Town,SouthAfrica 786 The Value of Confirmatory Testing in Early Infant HIV Diagnosis (EID) Programs 1 MassachusettsGeneralHosp,Boston,MA,USA; 2 McGawMedCntrof NorthwesternUniv,Chicago, IL,USA; 3 WHO,Geneva,Switzerland; 4 Univ ofCapeTown,CapeTown,SouthAfrica; 5 ICAP,ColumbiaUnivMailman SchofPH,NewYork,NY,USA 787 Diagnostic Accuracy of Cepheid Xpert HIV-1 Qual for Early Infant Diagnosis Sekesai Mtapuri-Zinyowera 1 ; Zibusiso Ndlovu 2 ; Emmanuel Farjado 3 ; Carol Metcalf 3 ; Kekeletso Kao 4 ; Maryam Rumaney 3 ; Elton Mbofana 2 ; Daniel Orozco 4 ; Helen Bygrave 3 Kathleen Powis 1 ; Sajini Souda 2 ; Shahin Lockman 3 ; Gbolahan Ajibola 4 ; Kara Bennett 5 ; Florence Chilisa 4 ; Michael Hughes 6 ; Sikhulile Moyo 7 ; Joseph Makhema 4 ; Roger L. Shapiro 6 Andrea L. Ciaranello 1 ; Jordan A. Francke 1 ; Divya Mallampati 2 ; Rachel L. MacLean 1 ; Martina Penazzato 3 ;Taige Hou 1 ; Landon Myer 4 ; Elaine J. Abrams 5 ; Rochelle P.Walensky 1 ; Kenneth A. Freedberg 1 1 NatlMicrobiologyReferenceLab,Harare,Zimbabwe; 2 MédecinsSans Frontières,Harare,Zimbabwe; 3 MédecinsSansFrontières,SouthernAfrica MedUnit,CapeTown,SouthAfrica; 4 FIND,Geneva,Switzerland

Maputo,Mozambique; 4 ClintonHlthAccess Initiative,Gabarone, Botswana; 5 InstNacionaldeSaude,Maputo,Mozambique

Session P-T1 Poster Abstracts

Hall D

2:45 PM-4:00 PM Pharmacokinetics: Efficacy and Safety of New ARVs in Children 815 Nevirapine (NVP) Concentrations in HIV-Infected Newborns Receiving Therapeutic Dosing Edmund Capparelli 1 ; Kenneth Maswabi 2 ; Steven Rossi 1 ; Muchaneta Bhondai 2 ; Sikhulile Moyo 3 ; Patrick Jean-Philippe 4 ; Michael Hughes 5 ; Mathias Lichterfeld 6 ; Daniel Kuritzkes 7 ; Roger L. Shapiro 5 1 UnivofCaliforniaSanDiego,SanDiego,CA,USA; 2 BotswanaHarvard AIDS InstPartnership,Gaborone,Botswana; 3 BotswanaHarvardAIDS InstPartnership,Gaborone,Botswana; 4 HenryM. JacksonFndn for the AdvancementofMilitaryMed, Inc,Rockville,MD,USA; 5 HarvardSchof PH,Boston,MA,USA; 6 Ragon InstofMGH,MITandHarvard,Cambridge, MA,USA; 7 HarvardMedSch,Boston,MA,USA 816 IMPAACT 1093: Dolutegravir in 6- to 12-Year-Old HIV-Infected Children: 48-Week Results AndrewWiznia 1 ; Carmelita Alvero 2 ;Terry Fenton 3 ; Kathleen George 4 ; EllenTownley 5 ; Rohan Hazra 6 ; Bobbie Graham 7 ; Annie Buchanan 8 ; CindyVavro 9 ; RolandoViani 10 ; for the IMPAACT P1093 Study Group 1 AlbertEinsteinCollofMed,Bronx,NY,USA; 2 HarvardSchofPH,Boston, MA,USA; 3 SDAC,HarvardSchofPH,Boston,MA,USA; 4 IMPAACT Operations,Durham,NC,USA; 5 NIH,Rockville,MD,USA; 6 EuniceKennedy ShriverNICHD,Bethesdah,MD,USA; 7 FrontierSci&TechRsrFndn, Inc, Buffalo,NY,USA; 8 GSK,ResearchTrianglePark,NC,USA; 9 ViiVHlthcare, ReserachTrianglePark,NC,USA; 10 UnivofCaliforniaSanDiego,San Diego,CA,USA 817 Safety and Efficacy of E/C/F/TAF in HIV-1 Infected Treatment-Naïve Adolescents Aditya Gaur 1 ; Hilda Kizito 2 ; Rana Chakraborty 3 ; Jagmohan Batra 4 ; Pope Kosalaraksa 5 ;Wicharn Luesomboon 6 ;Yongwu Shao 7 ; Devi SenGupta 7 ; Martin S. Rhee 7 ; Erin Quirk 7 1 St JudeChildren’sRsrHosp,Memphis,TN,USA; 2 JointClinicalRsrCntr, Kampala,Uganda; 3 EmoryUniv,Atlanta,GA,USA; 4 MillerChildren’sHosp, LongBeach,CA,USA; 5 KhonKaenUniv,KhonKaen,Thailand; 6 Queen SavangVadhanaMemorialHosp,ChonBuri,Thailand; 7 GileadScis, Inc, FosterCity,CA,USA

Poster Listings

71

CROI 2016